George Syrmalis
Follow
Get notifications in MyBN when activity occurs.
George Syrmalis
Executive Chairman, Chief Executive Officer / IQ3CORP
Most Notable Role
Dr Syrmalis founded and led as CEO and the Chair, the Bionuclear Group SA, (1995-2005) incorporating Antisoma SA, Bionuclear Institute of Diagnosis and Therapy SA, Bionuclear Research and Development SA, and Vitalcheck SA.
Lists and Charts
Total Shareholder Return as at 26/02/21
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 584th | Cokal | 89% | 15% |
| 817th | Farmaforce | 46% | -18% |
| 1335th | Skyfii | 0% | -20% |
| 1435th | 360 Capital Group | -7% | 9% |
| 1686th | Nova Eye Medical | -33% | -8% |
1741 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 540th |  | Farmaforce | $14.6m |
| 551st | | Skyfii | $13.6m |
| 552nd | | Cokal | $13.6m |
| 554th | | Nova Eye Medical | $13.0m |
| 555th | | 360 Capital Group | $12.9m |
1217 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
 | NEW ROLE: Executive Chairman, Chief Executive Officer, IQ3CORP | 03 Nov 2020 |
| NEW ROLE: Non-Executive Director, Farmaforce | 03 Nov 2020 |
